March 3, 2026

Clinical course and prognostic risk factors of SARS-CoV-2 vaccine-related hepatitis: differentiating severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury from autoimmune hepatitis

Puntos clave

Vaccine-associated liver injury resembles DI-ALH, necessitating careful differentiation from autoimmune hepatitis.
A subset of cases may require long-term immunosuppression, indicating complex underlying mechanisms.
Analysis of clinical courses shows significant variations in symptoms and treatment responses across cases.
Findings highlight the need for ongoing monitoring and potential changes in treatment protocols for affected individuals.

Resumen

Most cases resemble DI-ALH, which we propose naming severe acute respiratory syndrome coronavirus 2 vaccine-associated liver injury, but a significant subset requires long-term immunosuppression, resembling classical AIH.

Me gusta

Guardar

Cite This Study

Malino et al. (Wed,) studied this question.

synapsesocial.com/papers/69a75bf8c6e9836116a243e7 https://doi.org/https://doi.org/10.1097/meg.0000000000003142

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

Me gusta

Guardar